Leqembi's full approval and the future of Alzheimer's treatment
In this episode of "The Top Line," Fierce's Fraiser Kansteiner engages in a conversation with Alexander Scott, senior vice president of integrity at Eisai, to discuss the full approval of Leqembi and what it means for Eisai and, most importantly, for Alzheimer's patients.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Create your
podcast in
minutes
It is Free